Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction.

Gasecka A, Nieuwland R, Budnik M, Dignat-George F, Eyileten C, Harrison P, Huczek Z, Kapłon-Cieślicka A, Lacroix R, Opolski G, Pluta K, van der Pol E, Postuła M, Leroyer A, Siljander P, Sturk A, Filipiak KJ.

Platelets. 2018 Dec 26:1-7. doi: 10.1080/09537104.2018.1557616. [Epub ahead of print]

PMID:
30585111
2.

Tissue Factor Coagulant Activity is Regulated by the Plasma Membrane Microenvironment.

Yu Y, Böing AN, Hau CM, Hajji N, Ruf W, Sturk A, Nieuwland R.

Thromb Haemost. 2018 Jun;118(6):990-1000. doi: 10.1055/s-0038-1642031. Epub 2018 Apr 21.

PMID:
29679947
3.

Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets.

Yu Y, Gool E, Berckmans RJ, Coumans FAW, Barendrecht AD, Maas C, van der Wel NN, Altevogt P, Sturk A, Nieuwland R.

J Thromb Haemost. 2018 Jun;16(6):1153-1163. doi: 10.1111/jth.14023. Epub 2018 May 17.

PMID:
29658195
4.

Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation.

van der Pol E, Sturk A, van Leeuwen T, Nieuwland R, Coumans F; ISTH-SSC-VB Working group.

J Thromb Haemost. 2018 Jun;16(6):1236-1245. doi: 10.1111/jth.14009. Epub 2018 Apr 26.

PMID:
29575716
5.

Comparison of Generic Fluorescent Markers for Detection of Extracellular Vesicles by Flow Cytometry.

de Rond L, van der Pol E, Hau CM, Varga Z, Sturk A, van Leeuwen TG, Nieuwland R, Coumans FAW.

Clin Chem. 2018 Apr;64(4):680-689. doi: 10.1373/clinchem.2017.278978. Epub 2018 Feb 16.

6.

Absolute sizing and label-free identification of extracellular vesicles by flow cytometry.

van der Pol E, de Rond L, Coumans FAW, Gool EL, Böing AN, Sturk A, Nieuwland R, van Leeuwen TG.

Nanomedicine. 2018 Apr;14(3):801-810. doi: 10.1016/j.nano.2017.12.012. Epub 2018 Jan 5.

7.

Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.

van Baal JOAM, van Noorden CJF, Nieuwland R, Van de Vijver KK, Sturk A, van Driel WJ, Kenter GG, Lok CAR.

J Histochem Cytochem. 2018 Feb;66(2):67-83. doi: 10.1369/0022155417742897. Epub 2017 Nov 22. Review.

8.

Surface Plasmon Resonance is an Analytically Sensitive Method for Antigen Profiling of Extracellular Vesicles.

Gool EL, Stojanovic I, Schasfoort RBM, Sturk A, van Leeuwen TG, Nieuwland R, Terstappen LWMM, Coumans FAW.

Clin Chem. 2017 Oct;63(10):1633-1641. doi: 10.1373/clinchem.2016.271049. Epub 2017 Aug 7.

9.

Wound scabs protect regenerating tissue against harmful ultraviolet radiation.

van der Pol E, Mudde YD, Coumans FA, van Leeuwen TG, Sturk A, Nieuwland R.

Med Hypotheses. 2016 Nov;96:39-41. doi: 10.1016/j.mehy.2016.09.011. Epub 2016 Sep 21.

PMID:
27959273
10.

The histophysiology and pathophysiology of the peritoneum.

van Baal JO, Van de Vijver KK, Nieuwland R, van Noorden CJ, van Driel WJ, Sturk A, Kenter GG, Rikkert LG, Lok CA.

Tissue Cell. 2017 Feb;49(1):95-105. doi: 10.1016/j.tice.2016.11.004. Epub 2016 Nov 13. Review.

PMID:
27890350
11.

Handling and storage of human body fluids for analysis of extracellular vesicles.

Yuana Y, Böing AN, Grootemaat AE, van der Pol E, Hau CM, Cizmar P, Buhr E, Sturk A, Nieuwland R.

J Extracell Vesicles. 2015 Nov 11;4:29260. doi: 10.3402/jev.v4.29260. eCollection 2015.

12.

Strategies to reduce wastage of red blood cell units.

Bots M, de Grouw EP, van Rooyen-Schreurs IH, van den Akker GJ, Sturk A, Klinkspoor JH, Zeerleder SS.

Vox Sang. 2016 Feb;110(2):143-9. doi: 10.1111/vox.12351. Epub 2015 Oct 28.

PMID:
26509641
13.

Accuracy and Reproducibility in Quantification of Plasma Protein Concentrations by Mass Spectrometry without the Use of Isotopic Standards.

Kramer G, Woolerton Y, van Straalen JP, Vissers JP, Dekker N, Langridge JI, Beynon RJ, Speijer D, Sturk A, Aerts JM.

PLoS One. 2015 Oct 16;10(10):e0140097. doi: 10.1371/journal.pone.0140097. eCollection 2015.

14.

Clinical Significance of Tissue Factor-Exposing Microparticles in Arterial and Venous Thrombosis.

van Es N, Bleker S, Sturk A, Nieuwland R.

Semin Thromb Hemost. 2015 Oct;41(7):718-27. doi: 10.1055/s-0035-1556047. Epub 2015 Sep 26. Review.

PMID:
26408926
15.

Creatine kinase inhibits ADP-induced platelet aggregation.

Horjus DL, Nieuwland R, Boateng KB, Schaap MC, van Montfrans GA, Clark JF, Sturk A, Brewster LM.

Sci Rep. 2014 Oct 9;4:6551. doi: 10.1038/srep06551.

16.

Single-step isolation of extracellular vesicles by size-exclusion chromatography.

Böing AN, van der Pol E, Grootemaat AE, Coumans FA, Sturk A, Nieuwland R.

J Extracell Vesicles. 2014 Sep 8;3. doi: 10.3402/jev.v3.23430. eCollection 2014.

17.

Refractive index determination of nanoparticles in suspension using nanoparticle tracking analysis.

van der Pol E, Coumans FA, Sturk A, Nieuwland R, van Leeuwen TG.

Nano Lett. 2014 Nov 12;14(11):6195-201. doi: 10.1021/nl503371p. Epub 2014 Oct 2.

PMID:
25256919
18.

Effects of cancer on platelets.

van Es N, Sturk A, Middeldorp S, Nieuwland R.

Semin Oncol. 2014 Jun;41(3):311-8. doi: 10.1053/j.seminoncol.2014.04.015. Epub 2014 Apr 24. Review.

PMID:
25023347
19.

Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation.

Yuana Y, Levels J, Grootemaat A, Sturk A, Nieuwland R.

J Extracell Vesicles. 2014 Jul 8;3. doi: 10.3402/jev.v3.23262. eCollection 2014.

20.

Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing.

van der Pol E, Coumans FA, Grootemaat AE, Gardiner C, Sargent IL, Harrison P, Sturk A, van Leeuwen TG, Nieuwland R.

J Thromb Haemost. 2014 Jul;12(7):1182-92. doi: 10.1111/jth.12602. Epub 2014 Jun 19.

21.

Active caspase-3 is removed from cells by release of caspase-3-enriched vesicles.

Böing AN, Stap J, Hau CM, Afink GB, Ris-Stalpers C, Reits EA, Sturk A, van Noorden CJ, Nieuwland R.

Biochim Biophys Acta. 2013 Aug;1833(8):1844-52. doi: 10.1016/j.bbamcr.2013.03.013. Epub 2013 Mar 24.

22.

Laboratory evaluation of the Coasys® Plus C coagulation analyzer.

de Bie P, Schornagel WJ, van den Dool EJ, Bakker B, van Dam W, Heckman M, Ağar C, Sturk A, Stroobants AK.

Thromb Res. 2013 Apr;131(4):357-62. doi: 10.1016/j.thromres.2013.02.004. Epub 2013 Mar 6.

PMID:
23473640
23.

Extracellular vesicles in physiological and pathological conditions.

Yuana Y, Sturk A, Nieuwland R.

Blood Rev. 2013 Jan;27(1):31-9. doi: 10.1016/j.blre.2012.12.002. Epub 2012 Dec 20. Review.

24.

Acetylsalicylic acid prevents platelet-induced proarrhythmic effects on intracellular Ca2+ homeostasis in ventricular myocytes.

Zakhrabova-Zwiauer OM, Verkerk AO, de Jong JS, Sturk A, Nieuwland R, Tan HL.

Int J Cardiol. 2013 Jul 15;167(1):303-5. doi: 10.1016/j.ijcard.2012.09.188. Epub 2012 Oct 16. No abstract available.

25.

Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology.

Kleinjan A, Böing AN, Sturk A, Nieuwland R.

Thromb Res. 2012 Oct;130 Suppl 1:S71-3. doi: 10.1016/j.thromres.2012.08.281. Review.

26.

Inappropriate use of the faecal occult blood test in a university hospital in the Netherlands.

van Rijn AF, Stroobants AK, Deutekom M, Lauppe C, Sturk A, Bossuyt PM, Fockens P, Dekker E.

Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1266-9.

PMID:
23022920
27.

Comparative study of blood collection tubes and thromboplastin reagents for correction of INR discrepancies: a proposal for maximum allowable magnesium contamination in sodium citrate anticoagulant solutions.

van den Besselaar AM, van Zanten AP, Brantjes HM, Elisen MG, van der Meer FJ, Poland DC, Sturk A, Leyte A, Castel A.

Am J Clin Pathol. 2012 Aug;138(2):248-54. doi: 10.1309/AJCPGSB5YPJRREEV.

PMID:
22904137
28.

Classification, functions, and clinical relevance of extracellular vesicles.

van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R.

Pharmacol Rev. 2012 Jul;64(3):676-705. doi: 10.1124/pr.112.005983. Epub 2012 Jun 21. Review.

PMID:
22722893
29.

Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.

van Doormaal F, Kleinjan A, Berckmans RJ, Mackman N, Manly D, Kamphuisen PW, Richel DJ, Büller HR, Sturk A, Nieuwland R.

Thromb Haemost. 2012 Jul;108(1):160-5. doi: 10.1160/TH12-02-0099. Epub 2012 Apr 26.

PMID:
22535219
30.

Single vs. swarm detection of microparticles and exosomes by flow cytometry.

van der Pol E, van Gemert MJ, Sturk A, Nieuwland R, van Leeuwen TG.

J Thromb Haemost. 2012 May;10(5):919-30. doi: 10.1111/j.1538-7836.2012.04683.x.

31.

Postprandial changes in the phospholipid composition of circulating microparticles are not associated with coagulation activation.

Tushuizen ME, Diamant M, Peypers EG, Hoek FJ, Heine RJ, Sturk A, Nieuwland R.

Thromb Res. 2012 Jul;130(1):115-21. doi: 10.1016/j.thromres.2011.09.003. Epub 2011 Oct 2.

32.

The functions of microparticles in pre-eclampsia.

van der Post JA, Lok CA, Boer K, Sturk A, Sargent IL, Nieuwland R.

Semin Thromb Hemost. 2011 Mar;37(2):146-52. doi: 10.1055/s-0030-1270342. Epub 2011 Mar 2. Review.

PMID:
21370216
33.

Cell-derived vesicles exposing coagulant tissue factor in saliva.

Berckmans RJ, Sturk A, van Tienen LM, Schaap MC, Nieuwland R.

Blood. 2011 Mar 17;117(11):3172-80. doi: 10.1182/blood-2010-06-290460. Epub 2011 Jan 19.

PMID:
21248061
34.

The functions of microparticles in preeclampsia.

Lok CA, Van der Post JA, Sturk A, Sargent IL, Nieuwland R.

Pregnancy Hypertens. 2011 Jan;1(1):59-65. doi: 10.1016/j.preghy.2010.10.006. Epub 2010 Nov 5.

PMID:
26104232
35.

Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?

Tushuizen ME, Diamant M, Sturk A, Nieuwland R.

Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):4-9. doi: 10.1161/ATVBAHA.109.200998. Review.

PMID:
21160062
36.

Microparticles and exosomes in gynecologic neoplasias.

Nieuwland R, van der Post JA, Lok CA, Kenter G, Sturk A.

Semin Thromb Hemost. 2010 Nov;36(8):925-9. doi: 10.1055/s-0030-1267046. Epub 2010 Nov 3. Review. Erratum in: Semin Thromb Hemost. 2011 Feb;37(1):95. Gemma, Christianne A R Lok [corrected to Lok, Christianne A R]; Kenter, G [corrected to Kenter, Gemma].

PMID:
21049392
37.

Complement activation on the surface of cell-derived microparticles during cardiac surgery with cardiopulmonary bypass - is retransfusion of pericardial blood harmful?

Biró E, van den Goor JM, de Mol BA, Schaap MC, Ko LY, Sturk A, Hack CE, Nieuwland R.

Perfusion. 2011 Jan;26(1):21-9. doi: 10.1177/0267659110385742. Epub 2010 Oct 21.

PMID:
20965956
38.

Optical and non-optical methods for detection and characterization of microparticles and exosomes.

van der Pol E, Hoekstra AG, Sturk A, Otto C, van Leeuwen TG, Nieuwland R.

J Thromb Haemost. 2010 Dec;8(12):2596-607. doi: 10.1111/j.1538-7836.2010.04074.x. Review.

39.

Why do cells release vesicles?

Nieuwland R, Sturk A.

Thromb Res. 2010 Apr;125 Suppl 1:S49-51. doi: 10.1016/j.thromres.2010.01.037. Epub 2010 Feb 11. Review.

PMID:
20149923
40.

C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation.

van der Zee PM, Biró E, Trouw LA, Ko Y, de Winter RJ, Hack CE, Sturk A, Nieuwland R.

Clin Immunol. 2010 Jun;135(3):490-5. doi: 10.1016/j.clim.2010.01.002.

PMID:
20138585
41.

Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.

van Eijk IC, Tushuizen ME, Sturk A, Dijkmans BA, Boers M, Voskuyl AE, Diamant M, Wolbink GJ, Nieuwland R, Nurmohamed MT.

Ann Rheum Dis. 2010 Jul;69(7):1378-82. doi: 10.1136/ard.2009.118372. Epub 2009 Nov 16.

PMID:
19919943
42.

Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease.

van Beers EJ, Schaap MC, Berckmans RJ, Nieuwland R, Sturk A, van Doormaal FF, Meijers JC, Biemond BJ; CURAMA study group.

Haematologica. 2009 Nov;94(11):1513-9. doi: 10.3324/haematol.2009.008938. Epub 2009 Oct 8.

43.

Human alternatively spliced tissue factor is not secreted and does not trigger coagulation.

Böing AN, Hau CM, Sturk A, Nieuwland R.

J Thromb Haemost. 2009 Aug;7(8):1423-6. doi: 10.1111/j.1538-7836.2009.03521.x. Epub 2009 Jun 22. No abstract available.

44.

Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia.

Lok CA, Jebbink J, Nieuwland R, Faas MM, Boer K, Sturk A, Van Der Post JA.

Am J Reprod Immunol. 2009 May;61(5):346-59. doi: 10.1111/j.1600-0897.2009.00701.x.

PMID:
19341385
45.

[Routine platelet aggregation inhibition not useful when using acetylsalicylic acid or clopidogrel].

Kramer MC, Nieuwland R, Sturk A, de Winter RJ.

Ned Tijdschr Geneeskd. 2009 Jan 31;153(5):190-5. Review. Dutch. No abstract available.

PMID:
19256247
46.

Relation of N-terminal pro B-type natriuretic peptide levels after symptom-limited exercise to baseline and ischemia levels.

van der Zee PM, Verberne HJ, van Spijker RC, van Straalen JP, Fischer JC, Sturk A, van Eck-Smit BL, de Winter RJ.

Am J Cardiol. 2009 Mar 1;103(5):604-10. doi: 10.1016/j.amjcard.2008.11.006. Epub 2008 Dec 26.

PMID:
19231320
47.

Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia.

Lok CA, Van Der Post JA, Sargent IL, Hau CM, Sturk A, Boer K, Nieuwland R.

Hypertens Pregnancy. 2008;27(4):344-60. doi: 10.1080/10641950801955733.

PMID:
19003636
48.

Circulating platelet-derived and placenta-derived microparticles expose Flt-1 in preeclampsia.

Lok CA, Böing AN, Sargent IL, Sooranna SR, van der Post JA, Nieuwland R, Sturk A.

Reprod Sci. 2008 Dec;15(10):1002-10. doi: 10.1177/1933719108324133. Epub 2008 Oct 20.

PMID:
18936439
49.

Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent.

Diamant M, Tushuizen ME, Abid-Hussein MN, Hau CM, Böing AN, Sturk A, Nieuwland R.

Thromb Haemost. 2008 Sep;100(3):489-97.

PMID:
18766267
50.

Increases in myeloperoxidase levels after exercise in myocardial perfusion scintigraphy are not induced by myocardial ischemia.

van der Zee PM, Meuwese MC, Verberne HJ, de Ruijter M, van Straalen JP, Fischer JC, Sturk A, van Eck-Smit BL, Stroes ES, de Winter RJ.

Clin Chim Acta. 2008 Sep;395(1-2):146-50. doi: 10.1016/j.cca.2008.06.011. Epub 2008 Jun 15.

PMID:
18601914

Supplemental Content

Support Center